Facultat de Psicologia (Universitat de Barcelona)
Barcelona, 08035, Spain
NCT Number: NCT04025749
This study aims to conduct a single-blind randomized controlled trial with sixty children with Cerebral Palsy (CP) to explore if a home-based computerized multi-modal executive training is effective improving infants' executive functions (EF), as the primary outcome. As secondary outcomes, it will be tested if the intervention exerts a positive effect on other cognitive functions, social relationships, and quality of life (QOL) in children with CP. It is expected to observe changes in brain structure and functioning associated to clinical improvements.
The primary hypothesis to be tested is that a computerized multi-modal cognitive training will be more effective at improving EF than usual care alone.
Secondary hypotheses are that the computerized therapy will be more effective than usual care alone at improving specific cognitive functions such as visuoperception, memory, social relationships and QOL. In addition, we also hypothesize there will be changes on brain structure and function. We further hypothesise that these changes will be maintained over time (9 months). Finally, sociodemographic and clinical factors are expected to be related with the level of efficacy of the computerized multi-modal cognitive training.
Looking for future studies?
Notify Me8 year–12 year
All sexes
Interventional
Not applicable
Barcelona, 08035, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home-based executive function training with adaptive difficulty, through NeuronUp (https://www.neuronup.com) over 12 weeks (30 min/day, 5 days per week, 30h in total).
Care as usual
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Spatial Span, Wechsler Nonverbal Scale of Ability (WNV)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Digit Span, Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Five Digit Test (FDT)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Auditory attention and Response Set, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Word Generation, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Tower Test, Delis-Kaplan Executive Function System (D-KEFS)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Conners' Continuous Performance Test-II (CPT-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Theory of Mind, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Affect Recognition, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Benton Facial Recognition Test (BFRT)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Arrows, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Memory for designs, A Developmental NEuroPSYchological Assesment-II (NEPSY-II)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Word selective reminding, Test of Memory and Learning (TOMAL)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Participation and Environment Measure for Children and Youth (PEM-CY)
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Cerebral Palsy Quality of Life (CP QOL-CHILD) questionnaire. CP QOL-CHILD is a proxy-reported questionnaire and QOL is measured as an index score (range from 0 to 100).
Time frame: T0: 1 week before beginning; T1: 1 week immediately after training; T2: follow up (nine month after finished training)
Structural and functional (resting state) magnetic resonance images (MRI)
University of Barcelona
Other
Executive Training in Cerebral Palsy: Participation, Quality of Life and Brain Connectivity
Acronym: ETCONNECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729800
Brain Damage, Chronic, Brain Diseases
Lahore, Pakistan
View Trial DetailsNCT07683338
Bilateral Spastic Cerebral Palsy, Brain Damage, Chronic
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT07706517
Brain Damage, Chronic, Brain Diseases
Saint-Etienne, France
View Trial DetailsNCT05791877
Brain Damage, Chronic, Brain Diseases
Wilmington, Delaware, United States
View Trial Details